News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
New publication led by Julie Ritter on Novel Framework of Financial Hardship in Childhood Cancer
Photo taken from Julie Ritter/LinkedIn
Sep 4, 2024, 16:55

New publication led by Julie Ritter on Novel Framework of Financial Hardship in Childhood Cancer

Felicia Marie Knaul, Director of the University of Miami Institute for Advanced Study of the Americas, shared on LinkedIn:

“Proud to share new publication led by Julie Ritter, St. Jude Children’s Research Hospital – ALSAC: Novel Framework of Financial Hardship in Childhood Cancer: Incorporating Stakeholder Perspectives, JCO Global Oncology.

Although financial hardship in childhood cancer contributes to poor outcomes, no standardized tool to assess its impact exists.

Existing methods are heterogeneous and designed using high-income country (HIC), adult perspectives.

This project aimed to construct a stakeholder-informed conceptual framework of financial hardship in childhood cancer with global relevancy.

With Beverley Essue, João Marcelo Bragança, carmen auste, Alejandra Mendez, Patrícia Loggetto, Karla Emília de Sá Rodrigues, Andrés Felipe Fajardo, Phillip D. Cohen, Sara M. Malone, Troy Quast, Russell S. Kirby, Eva Steliarova-Foucher, I-Chan Huang, Filip Meheus, Nickhill Bhakta.”
Julie Ritter

Source: Felicia Marie Knaul/LinkedIn

Julie Ritter is a FHI. Previously she was the Program Manager of the Global Disease Burden and Simulation Unit at the St. Jude Children’s Research Hospital. She also served as a data analyst at University of Tennessee Health Science Center. 

Alejandra Mendez ALSAC Andrés Felipe Fajardo Beverley Essue cancer carmen auste Childhood Cancer Eva Steliarova-Foucher Felicia Marie Knaul Filip Meheus HIC high-income country I-Chan Huang JCO Global Oncology João Marcelo Bragança Julie Ritter Karla Emília de Sá Rodrigues Nickhill Bhakta OncoDaily Oncology Patrícia Loggetto Phillip D. Cohen Russell S. Kirby Sara M. Malone St. Jude Children's Research Hospital Troy Quast
Special Coverage
Blog
Jan 20, 2025, 04:32
Bevacizumab and carboplatin-pemetrexed chemotherapy with/out atezolizumab for advanced pleural mesothelioma
Blog
Jan 20, 2025, 04:29
Katsuaki Maehara: Lung EGFR mutations catalog
Opinion
Jan 20, 2025, 04:25
Elisabetta Bonzano: The identification and validation of patient-specific vulnerabilities
Blog
Jan 20, 2025, 04:21
Robin Zon: Behind every diagnosis, test, approval/ disapproval and outcome is a patient and their family
Insight
Jan 20, 2025, 04:14
Laura Bukavina discusses a paper on BCG treatment for patients with urothelial carcinoma of the prostatic urethra
Insight
Jan 20, 2025, 04:00
FDA approved datopotamab deruxtecan-dlnk for unresectable or metastatic, HR-positive, HER2-negative breast cancer
Career
Jan 20, 2025, 03:10
Lawrence “Larry” Deist Appointed to Board of Directors at Rally Foundation for Childhood Cancer Research
Blog
Jan 20, 2025, 02:54
Drew Moghanaki: A new medical oncology position at the VA Medical Center in Long Beach
Science
Jan 20, 2025, 02:44
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical HL
Science
Jan 20, 2025, 02:16
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer
Blog
Jan 20, 2025, 02:14
Akriti Jain: Grateful to present at Cleveland Clinic ASH review
Career
Jan 19, 2025, 23:12
Kimryn Rathmell Steps Down as NCI Director, Concluding a Pivotal Leadership Era